Constantinos Demetriou
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy.
Journal: Scientific reports
Published: May 15, 2023
p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer.
Journal: Cell death and differentiation
Published: November 18, 2022
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.
Journal: Frontiers in cellular neuroscience
Published: November 09, 2022
Ex vivo explant model of adenoma and colorectal cancer to explore mechanisms of action and patient response to cancer prevention therapies.
Journal: Mutagenesis
Published: November 03, 2021
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients.
Journal: Journal of visualized experiments : JoVE
Published: February 22, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice.
Journal: The Journal of biological chemistry
Published: January 12, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026